Park MS - Search Results

1

A preclinical model to assess the antigenicity of an HLA-A2 melanoma cell vaccine.

Hayashi Y, Hoon DS, Foshag LJ, Park MS, Terasaki PI, Morton DL. Hayashi Y, et al. Among authors: park ms. Cancer. 1993 Aug 1;72(3):750-9. doi: 10.1002/1097-0142(19930801)72:3<750::aid-cncr2820720319>3.0.co;2-v. Cancer. 1993. PMID: 8334627

2

Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A.

Hayashi Y, Hoon DS, Park MS, Terasaki PI, Morton DL. Hayashi Y, et al. Among authors: park ms. Cancer Immunol Immunother. 1992;34(6):419-23. doi: 10.1007/BF01741754. Cancer Immunol Immunother. 1992. PMID: 1373343 Free PMC article.

3

Induction of CD4+ cytotoxic T cells by sensitization with allogeneic melanomas bearing shared or cross-reactive HLA-A.

Hayashi Y, Hoon DS, Park MS, Terasaki PI, Foshag LJ, Morton DL. Hayashi Y, et al. Among authors: park ms. Cell Immunol. 1992 Feb;139(2):411-25. doi: 10.1016/0008-8749(92)90082-z. Cell Immunol. 1992. PMID: 1733512

4

Serologic and biochemical analysis of HLA B15 and B5 complexes.

Clark BD, Park MS, Tonai R, Terasaki PI. Clark BD, et al. Among authors: park ms. Hum Immunol. 1987 Sep;20(1):47-57. doi: 10.1016/0198-8859(87)90005-x. Hum Immunol. 1987. PMID: 3679902

5

Monoclonal antibody against A1 Lewis d antigen produced by the hybridoma immunized with a pulmonary carcinoma.

Iwaki Y, Kasai MK, Terasaki PI, Bernoco D, Park MS, Cicciarelli J, Heintz R, Saxton RE, Burk MW, Morton DL. Iwaki Y, et al. Among authors: park ms. Cancer Res. 1982 Feb;42(2):409-11. Cancer Res. 1982. PMID: 7055793

6

Relation between HLA-DW and the b-lymphocyte specificities.

Park MS, Terasaki PI, Saito S, Opelz G. Park MS, et al. Scand J Immunol. 1977;6(5):413-8. doi: 10.1111/j.1365-3083.1977.tb02097.x. Scand J Immunol. 1977. PMID: 70058

7

Serologically defined B-lymphocyte antigen expression in patients with malignant melanoma.

Nathanson SD, Park MS, Drew I, Morton DL, Terasaki PI. Nathanson SD, et al. Among authors: park ms. Surg Forum. 1979;30:147-9. Surg Forum. 1979. PMID: 317176 No abstract available.

8

Effect of mismatching serologically defined residues on kidney transplant survival.

Takemoto S, Terasaki PI, Park MS, Clark BD. Takemoto S, et al. Among authors: park ms. Transplant Proc. 1992 Aug;24(4):1266-8. Transplant Proc. 1992. PMID: 1379751

9

Standardization of HLA through an international cell exchange.

Loon J, Terasaki PI, Takemura S, Park MS. Loon J, et al. Among authors: park ms. Clin Transpl. 1987:453-8. Clin Transpl. 1987. PMID: 3154445

10

First and second B-lymphocyte antigen expression in malignant melanoma.

Nathanson SD, Park MS, Drew SI, Morton DL, Terasaki PI. Nathanson SD, et al. Among authors: park ms. Transplant Proc. 1980 Mar;12(1):118-20. Transplant Proc. 1980. PMID: 6966093 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,293 results

Search Page

Filters